Rajnikant Raut

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 03, 2026
LOXL2 deletion triggers TMJ osteoarthritis, while overexpression protects it from NF-κB-induced chondrocyte apoptosis.

Rajnikant Dilip Raut, Chumki Choudhury, Faiza Ali

|Oct 09, 2025
LSD1 Inhibition Induces MHC-I and Dendritic Cell Activation to Promote Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.

Amit Kumar Chakraborty, Lina Kroehling, Rajnikant Dilip Raut

|Jun 04, 2025
LOXL2 alleviates post-traumatic knee osteoarthritis and pain.

Faiza Ali, Rajnikant Dilip Raut, Chumki Choudhury

|Jun 04, 2025
LOXL2 Deletion Triggers TMJ Osteoarthritis While Overexpression Protects Against NF-κβ-Induced Chondrocyte Apoptosis.

Rajnikant Dilip Raut, Chumki Choudhury, Faiza Ali

|Jun 24, 2024
Mononuclear copper(II) complexes with polypyridyl ligands: synthesis, characterization, DNA interactions/cleavages and in vitro cytotoxicity towards human cancer cells.

Arabinda Muley, Sadananda Kumbhakar, Rajnikant Raut

|Mar 31, 2022
Mononuclear Co(II) polypyridyl complexes: synthesis, molecular structure, DNA binding/cleavage, radical scavenging, docking studies and anticancer activities.

Kalai Selvan Karumban, Arabinda Muley, Rajnikant Raut

Pageof 1